NVOS (Novo Integrated Sciences) Long-Term Debt: $0.06 Mil (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences Long-Term Debt?

Novo Integrated Sciences NVOS 12 Long-Term Debt is $0.06 Mil as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

Novo Integrated Sciences's Long-Term Debt for the quarter that ended in May. 2024 was $0.06 Mil.

Novo Integrated Sciences's quarterly Long-Term Debt stayed the same from Nov. 2023 ($0.06 Mil) to Feb. 2024 ($0.06 Mil) and stayed the same from Feb. 2024 ($0.06 Mil) to May. 2024 ($0.06 Mil).

Novo Integrated Sciences's annual Long-Term Debt declined from Aug. 2021 ($6.12 Mil) to Aug. 2022 ($1.11 Mil) and declined from Aug. 2022 ($1.11 Mil) to Aug. 2023 ($0.07 Mil).

Novo Integrated Sciences  (OTCPK:NVOS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Novo Integrated Sciences Long-Term Debt Related Terms

Novo Integrated Sciences Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences Long-Term Debt Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 0.95 6.12 1.11 0.07

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.06 0.06 0.06
NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.06 Mil mean?
Novo Integrated Sciences (NVOS) has a Long-Term Debt of $0.06 Mil as of May. 2024.
Is Novo Integrated Sciences' Long-Term Debt too high?
Novo Integrated Sciences' current Long-Term Debt is $0.06 Mil. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' Long-Term Debt compare to BACK and NHLG?
Novo Integrated Sciences' Long-Term Debt of $0.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Novo Integrated Sciences's current Long-Term Debt is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current Long-Term Debt of $0.06 Mil. The current Long-Term Debt is $0.06 Mil. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current Long-Term Debt is $0.06 Mil as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price